Sign in

CIK 0000818686

  • Large accelerated filer

TEVA PHARMACEUTICAL INDUSTRIES LTD

Sign in to watch
Ticker
TEVA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
Israel
Entity type
Operating
Phone
+972 39148213
Business address
TEVA PHARMACEUTICAL INDUSTRIES LIMITED, 124 DVORA HANEVI'A ST., TEL AVIV, Israel
Former names
TEVA PHARMACEUTICAL INDUSTRIES LIMITED
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,242,786
in 10 filings, $10.6M under 10b5-1 plans

Net −$33,242,786. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Date Insider Transaction Shares Price Value Owned after
2021-03-04 Dethlefs Sven EVP Global Marketing&Portfolio Sale −6,012 $10.57 $64K 77,975.7
2021-03-04 Dethlefs Sven EVP Global Marketing&Portfolio Option exercise · Restricted Share Units −13,930 27,861
2021-03-04 Daniell Richard Exec. VP, European Commercial Option exercise +15,920 27,793
2021-03-04 Daniell Richard Exec. VP, European Commercial Sale −7,513 $10.58 $80K 20,280
2021-03-04 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units −15,920 31,841
2021-03-03 O'Grady Brendan P. EVP, North America Commercial Option exercise +1,166 16,034.49
2021-03-03 O'Grady Brendan P. EVP, North America Commercial Sale −463 $10.86 $5K 15,571.49
2021-03-03 O'Grady Brendan P. EVP, North America Commercial Option exercise · Restricted Share Units −1,166 0
2021-03-03 Nazzi Gianfranco EVP, International Markets Option exercise +1,400 1,400
2021-03-03 Nazzi Gianfranco EVP, International Markets Sale −1,400 $10.88 $15K 0
2021-03-03 Nazzi Gianfranco EVP, International Markets Option exercise · Restricted Share Units −1,400 0
2021-03-03 Dethlefs Sven EVP Global Marketing&Portfolio Option exercise +1,400 70,663.7
2021-03-03 Dethlefs Sven EVP Global Marketing&Portfolio Sale −606 $10.86 $7K 70,057.7
2021-03-03 Dethlefs Sven EVP Global Marketing&Portfolio Option exercise · Restricted Share Units −1,400 0
2021-03-03 Daniell Richard Exec. VP, European Commercial Option exercise +2,101 12,866
2021-03-03 Daniell Richard Exec. VP, European Commercial Sale −993 $10.88 $11K 11,873
2021-03-03 Daniell Richard Exec. VP, European Commercial Option exercise · Restricted Share Units −2,101 0
2021-03-02 O'Grady Brendan P. EVP, North America Commercial Sale −15,085 $10.85 $164K 14,868.49
2021-03-02 Fridriksdottir Hafrun Executive VP, Global R&D Sale −50,000 $10.82 $541K 64,063.51
2021-03-01 Stark David Matthew Exec. VP Chief Legal Officer Sale −18,430 $10.83 $200K 2,974.39

Page 48 of 76 · 1,517 trades